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INTHODUCTION
Although

t~ere

is reference in literature of the

Nineteenth Century to syndromes similating the disease
(granulocytopenia)

9.8

W(~

know it todes, it "vas not un-

til the year 1922 that Schultz 8ctually described his
C8se as a disease entity and by so doing, stimulated
the interest of tne medical profession to further investigation.

This preliminary investigation has re-

sulted in unlimited publications on the various phases
of granulocytopenia and, as with any recently recognized
d1 seF.tse, h8 s flooded the literature with numerous hypotheses as to the etiology and rationale of treatment,
some of which are rather bizarre, other of

~hich

are

very logical, but all of which ere necessary steps in
the clarification of such an uncertain disease.

After

reviewing the literature on the subject, it is quite
apparent that the finel

~ord

has not

BB

yet been writ-

ten but that the work of the last five yeers has seemingly accomplished the most toward that end.
In this paper an attempt will be made to correlate
the various manifestations of the disease with special
refer ence to etiology, pathology and trea,trnent.

No at-

tempt is made in this paper to discuss the grBnulopenic
syndrome under the various classifications that have been
suggested because no classificetion has as yet been advanced which is satisfactory.

1

DEFINITION

Gra.nulocytic cytopenia is a greve disease involving a number of disputed etiological factors and
characterized by a marked reduction in total number of
white cells with a complete or nearly complete reduction in the percentage of granulocytes, accompanied by
aplastic, normal, or hyperplastic myeloid tissue.
Following the peripheral granulopenit:l there may be any
number of lesions or symptoms which might follow the
removal from the body of such an important defense mechanism.

The disease may be acute, recurrent, or

chronic.
This definition is taken with modification from
an article published in the Journal of The American
Medical Association of 1933 by Regina C. Beck, M. D.
(1 )

HISTORY

As stated in THE JOURNAL (2), the first description
of a condition simileting granulocytic cytopenia was
made by Turk in 1907.

However Turk failed to clistin-

guish his c?ses from the commoner leukopenia of overwhelming infection.

This suggestion made by Turk ap-
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parently did not stimulate sufficient interest for
further study until 1922 when 1Nerner Schultz, (3) described a number 'of CB.ses which revealed an almost complete absence of gre.nular cells a ssocie.ted with

8.

group

of pathological findings and symptoms which he declared
formed a. clinical entity.

It wa s not until the follow-

ing year that Friedmann gave the name of agranulocytic
angina to this syndrome described by Schultz. (4)
Although there is no reference to earlier description of a syndrome which can definitely be classed as
granulocytic cytopenia.

However there is no doubt that

such a symptom complex was described before 1907.

As

early as 1857, Gubler described a gangrenous angina
which he differentiated from diphtheria, and in 1865
Trousseau published

8.

similar description. (5)

Morrell

Me.ckenzie (6) in 1880, in his "Manua.l of Diseases of
the Thros.t and Nose", described a gangrene of the pharynx, distinguished it from diphtheria and scarlet fever,
and ca.lled it ttputrid sore

thro~lttl.

This term we.s used

commonly for about twenty years thereafter.
Pepper (4) states, "It is further interesting to
note that by the beginning of the new century the textbooks of nose and throat diseases had begun to omit the
heading '·putrid sore throatlt,. until by the time Schultz
described the syndrome there was no description in the
text-books which corresponded at all to the picture of

agranulocytic angina.

In recent text-books, of course,

this omission has been rectified by the description of
the syndrome under its present name."
Since 1922 there has been a constant and increasing study of this disease.

In 1927, Kastlin (7) col-

lected reports of 43 cases and reported two more, with
only three recoveries, a mortality of 93 'Dsr cent.
Kastlin believed tl:E t the di sea se ws.s not a clincial
entity because of t he variations in the cases reported.
Blumer (8) in 1930 reported a case beginning with numerous bOils ths.t became le.rge abscesses, the blood and
the clinical course essentially the same as in the cases
described by Schultz.

Harkins (9) reported eight ca. ses,

four of which he considered to be agranulocytic angina
and the other four of which he celled granulocytopenia
because of the anemia and hemorrhagic diathesis, although it answered Schultz's description otherwise.
Farley (10) ha s collected report s of s. serie s of csses
following the administration of arsphenamine, which had
an agranulocytic period following the therapy •
•

It is clear that there may be a variety of conditions associated with the low granulocyte count.

Stocke

(11) in 1930 divided the cases into three groups;

one

group answering the description of Schultz, a second
showing the presence of anemia, and the third a tendency to hemorrhage.
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B~cteriologic

anything definite.

study has not as yet yielded
Friedmann isolated Bacillus Pyo-

cyaneus from the blood stream once. (2)

Lovett (12)

fout;ld the SBme organism in the throat and determined
that the isolated organism in the throat caused a relative lowering of' the granulocyte count in rabbits.
Dasse (13) found the organism in the throat in almost
pure culture and confirmed Lovett's animal experiments.
Since Kastlin's report of forty-three cases in

1937 ~ there has been a marked incres.se in the number of
cases reported and in 1934 Madison and Squier (14) estimated that there were over five hundred cases on record.
In the last few years, along with the increasing
incidence and increasing number of cases reported, there
has been an unlimited amount of material written on the
different phases of the disease and much progress has
been made toward solving the etiology, as well BS in
the treatment of the disease.

NOMENCLATURE
Werner Schultz (3), in 1922 proposed the name agranulocytosis.

The supply of hematologic terms is sO

abunda. nt that there is little excuse of choosing such
an a.mbiguous term.

The term Cl8.me into the nomenclature

'5

no doubt, on account of its brevity.

Schultz undoubt-

edly chose the word agranulocyte to describe "neutro....
phils without granulation" which he had spen in blood
smea~s

from eases of leukemia (1).

Friedmann (15)

being impressed by the usual severe localization of the
process in the throat, suggested the name angina agranulocytica.

This name was likewise unfortunate in that

it implies that the granulocytopenia is a result of the
angina rather than a syndrome of unknown etiology_

It

is now known that cases do rarely occur without a.ngins.•
Baldridge and Needles (16) pointed out that if the deriva.tion of egranulocytosis is a.ssumed to be agranulocyteosis it would

me~m

an increased number of these very

special abnormal neutrophils.

On the other h?nd, if

the derivation is a-granulocyte-osis it would mean

~1n

absence of increase granulo cytes, or a normal count.
They, therefore suggested the name Idiopa.thic neutropenia, thus making it analegous to idiopa.thic aplastic
anemia and idiopa.thic thromboctopenia..

Kracke (17)

brought out the term granulocytopenia as more exactly
expressing the actual condition existing in the disease.
Boerner's (18) nomenclature is widely accepted and is
consistent with that of Kracke's.

His nomencls.ture

describes both variations in numbers and percentages
of white blood cells.

It is as follows:

r

o

NEU'rHOPENIA-""a decrease in neutrophils
LYMPHOPENIA--a. decrease in lymphocytes
GRANULOPENIA--a decrease in granulocytes
The terms suggested is fitting to such a classification
and expressive of the pathology.

Ma.ny terms have been

suggested, some o-f which are: (1) Mucositis necroticans
agranulocytica, monocytic angina, sepsis with granulocytopenia, and agranulosis.

Some of the better names

that have been suggested are:

idiopa.thic

neutopeni~l

by Baldridge and :Needles (16) malignant neutropenia
by Schilling (19), ma.lignant (fa.tal) and benign (recovered) neutropenia by Rosenthal, granulopenia by
Boerner (18), 2nd gr8nulocytopenia by Kracke. (17)
If a term were to be used which would most a.cura.te1y coincide with the definition of the disease one
would be forced to admit that granulocytopenia would
be the most fitting term.

It not only accurately des-

cribes the dieease but also, by similarity of name, is
suggestive of the misleading but more widely used terms
of agranulocytosis and agranulocytie angina.

For these

reasons, this syndrome will hereafter be referred to as
granulocytopenia.

CLASSn~ICATION

When Schultz (3) first described his cases of "a_
granulocytic smginal' he thought them to be a. disease en-

7

tity end it is still regarded as such of some authors.
(21)

Sc~ultz

described only the rapidly fatal type snd

thought it to be s. di sea se peculiar to women around forty who were approaching the menopause.
that time

m~my

However, since

excellent articles have appepred in the

literature tending to prove that there are different
ph~£88

of this malady, and that. it is well to classify

them under the primary and secondary types.

Kracke (17),

Roberts and Kracke (22), end likewise Piersol and
Steinfield (23) have classified the different types of
granulocytopenia in a most excellent mlSmner.
and Kracke classify them

8S

Roberts

follows:

1.

Agranulocytic states due to che~ic~l~
pOisons, as benzene or arsenic. Agran~
ulotoxicosis.

2.

Agranulocytic stetes due to bacterial
infection. Agranulosepsis.

3.

Agranulocytic states due to irradiation,
as 8.fter radium and x-ray. Agrenuloradiation.

4.

Agranulocytoxis, a disease entity, in
which an unkown casue results in marrow,
b~ood, and clinical onsets in the order
named and characterized by single or recurrent acute attacks.

5.

Aplastic anemia, with or without acute
terminal infection.

6.

Pernicious anemia, terminal stAte.

7.

Acute aleukemic lymphatic leukemia with
or without acute terminal infection.

8.

Bizarre anemias and bizarre proportions
of the lymphocyte and monocytes.
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9.
10.

Roseola infantilis.
Acute infectious diseases associated
with or followed by leukopenia and
rar~ly near agranulocytic states-typhus, typhoid, mumpe, measles, malaria", influenz,a, dengue, phlebotomus
fever, Eygptian splenomegaly, and
certain pneumonias.

Piersol and Steinfield (23) believe that the syndrome described by Schultz merits the terms of prime.ry.
granulopenia, and that instances without discoverable
cause and corresponding to his original description
should properly fit into this cl':ttegory.

The term sec-

ondary grt:lOulopenia., they think, seems appropriate for
the larger group of cases due, to known causee.
term primary granulopenia therefore, seems to

The
corres~

pond favorably with number (4) or (Agranulocytosis)
of Roberts and Krackets classification.

Piersol: and

Steinfield suggested the following classification:
PRI~~RY

GRANULOPENIA

1.

Acute (Schultz)

2.

Chronic (recurrent)

SECONDAHY GRANULOPENIA
1.

General infections
Influenza,
Typhoid
Some exanthemasa
Q
•
)",Iepsls,
e t c •.

2.

Foeal infections.

3.

Chemical (arsphenamine,
benzene).

4.

Irradiation (x-rays,
radium).

5.

Blood diseases (leukemia, spleenic disease, aplastic anemia,
etc. ) •
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Sachs (21) fee,ls thAt the primary group should be
divided into the acute, subacute, and chronic recurrent.
He adds the subacute because two of his cases were subacute and not of a chronic recurring nature.
Rosenthal (20) in his

classific~tion

made etcording

to the clinci8l manisfeststions and course, divided neutropenia into malignant (fatal) and benign (recovered) cases.
Beck (1) suggests that it might be well to divide these
into two main classes as follows:

(1) primary benign

and primary malignant neutropenia, in which the etiology
is unknown;

(2) secondRry benign and secondary rnalig-

nant neutropenia, the cases in which the etiologic agents
are evident or in which one is dealing with examples of
well recognized clinical entities.
Madisonts classification is similar to that of
Piersol and Steinfield except that he adds another subdivision to that of secondary granulopenias, namely,
that of allergy.

However he admits that the question

of allergy is still far from settled insofar as its
etiological roll is concerned.
From the above, it is quite evident' how unsatisfactory attempts at
been.

£1

classification of this disease. have

The numerous classifications suggested all are

based on an etiological baeis and as the etiology of
this disease is still quite Obscure, is it not foolhardy
~

to attempt to classify the disease on such a basis?
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PHYSIOLOGY
Much of the accuracy in interpretation of the
blood picture in cUsease is dependent upon an understanding

0:1:'

the underlying mechanism of hemopoesis.

The .many

technics which have been developed for the study of the
cells of the blood, together with data on cell origins
and differentation obte.ined from embryologic and experimental investigations, now provide at least a working
basis for the approach of the dyscrasias involving the
hemopoetic system.

There are very few pathological con-

ditions with which the body has to det:tl, in which one,
or more, of the types of cells represented in the circulating blood is not secondarily involved.
circulating cellular elements
ant

~:md

~ay

That these

represent an import-

powerful increment in the defense forces of the

body is a fa.ct attested by repeated observB.tion.
Lowell Gulla.nd (25) looks forward to the time when the
differential count will be more important tha.n the

8.US-

cultation of the heart.
Maximow( 26} describes the granulocytes in the fOllowing' manner.

In contra.st to the lymphocytes and mono-

cytes, the granulocytes alvvays contain granules eleboreted in their protoplasm.

These gra.nules are the same

in a. given cell but VtU'y in different species and in
the different cells of the same species.

Another gen-
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eral characteristic of the mature granulocyte is the
shape of its nucleus, it being lobated instead of constricted or spherical as in the monocyte and

l~yphocyte.

The granulocytes fall into three gener!:tl group$designB.ted as:
ophil

(l) acidophil, (2) basophil, a.nd (3) heter-

leucocytes~

In the first the granules in the

protoplasm are most often spherical or oval and are electively stained with acid dyes;

in the

s~cond,

they

are of similar form, but stain electively wtth basic
dyes;

While in the third group the granule$, although

constant in particular species, differ as tq form, size,
and staining reaction according to species.
One of the striking properties of the leucocyte is
amebism.
ophils.

This property is most prominent in the heterThe amebism probably expl8ins in p,rt why the

leucocytes are not confined to the system of blood or
lymph vessels, but may be found everywhere in the tissues.

The leucocytes, in all probability p$rform their
I

functions only when outside the wascular system.
I

these cells are needed in any place of the

If

~rganism,

they assemble rapidly in the blood vessels 9f the region
and migrate into the tissues.
The phagocytic activity of the

leucocy~e

is inti-

mately connected with its amebi sm and a s one- would expect
is most pronounced in the heterophils.

Phagocytosis is

of great biological importance a.s it is one of the meE;ms
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by which

~he

It has

host destroys bacteria.
8.180

been shown tte t the heterophil

gr~m ..

ulocytes contain proteolytic and oxidizing enzymes.
The eosinophils display phagocytosis rarley if ever;
however their granules give a marked oxidase reaction.
The function of the baso phils and the cherild:cal nature
of their granules is unknown.
Roberts

~md

Kracke (22) have found that the loss

of the granulocytes from the body for seven days is incompatible with life •. Granulocytes are one of the chief
sources of immunity, and with their disintegration and
release of ferments, they give much a.ctive
to the body_

da~ly

immunity

The heterophils are also thought to be the

source of complement as well as the various immune bodies
such as hemolysins, precipitins and baeteriolysins. (1)
The life span of the neutrophil in the blood stream
has been shown to be approximately four days _ (22)

IProm

this some idea can be obtained of the enormous numbers
of granulocytes consumed daily by physiological degeneration.
'rhe bone marrow throughout extra-uterine Ii fe is
the natural source of erythrocytes, thrombocytes, and
the three types of granulocytes. (27)

The phagocytic

macrophages (clasmatocytes), while always present in
the marrow, are quite as regularly and normally found
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in spleen, liver, and diffuse connective tissues of
the body.

However their size and ability to arise

in situ throughout the body, as the need presents,
tends to minimize their appearance in the circulation.
(28) (29)

Lymphocytes and monocytes, the remaining

elements, which utilize the vascular bed as an avenue
of distribution, develop in the lymph nodes, "Spleen,
and in the more diffuse lymphoid ana. connective tissues of the body.

Hence, hemopoesis in its broadest

sense involves bone marrow, spleen, lymph nodes, connective tissue and the vascular and lymphatic systems.

(27)
Confusion has existed, and still prevails, among
hematologists relative to the origins and relationships
of the cells of the blood.

Rov/ever it is agreed that

!ll take their first beginning from the mesenchymal cells
of the

mesoderms~l

layer in the embryo.

But thereafter

the theories and hypotheses diverge more or less rs,dic8.l1y;

however the essentia.l differences a.rise more

in the interpretation and nomenclature than in opposing
. objective observations.

In the usual hyperplastic reo.

marrow, where blood cells are developing, it is difficult to distinguish the tissue landmarks, which separate
and segregate the units comprisi ng different cell stra ins.
This difficulty has been obviated by certain investigators
through a study of less complex areas, either experimentally

pro~uced

(30) (31) or naturally occuring, as in the

14

zone between red and yellow me.rrow when hemopoesis is
extending. (32)

Under these conditions erythrogenesis

has been observed to. occur in foci separate and distinct from myelogenic centers !md it is from this rna...
terial that we have learned most about the relative
location, distribution,

~md

ythrocytes and gra.nulocytes.

independent origin of erOne of the 'principal dif

ficulties to an unanimous egreerr:ent upon these intercellular relationships resides in the fact that the
all of the cells of the blood continue to arise threughout life as

primitive, immature elements incapable of

performing thei,r specific functions until after completion af

p

definite maturation'cycle.

Most of the cri-

teria characteristic of the definitive cells, and which
form the be. sis for morphological differentiation and
elassification, areelaboreted during this maturation
period.

Hence, the earli-er precursors of each strain

of cells lack, in direct proportion to their immaturity,
clear cut distinguishing' features upon which hemetologists can agree.
Ma.ximow (33), in his studies, including both embryonic end adult tissues, was convinced of the hemocytogenic function of the "1ymphocyte it , in which exits 80lely to be played' upon by the vprious forces of the body,
with the corresponding cellular differentiation being
a direct result of the need of the moment.

Cunningham,

Sabin, and D08n (34) conclude from their studies that
a primitive stem cell for the white blood cells may be
recO
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recognized in the bone marrow, lymph nodes, spleen,
end connective tissues.

Fixed cells in the reticulum

of these orgpns give rise by mitosis to a free primitive cell, the size of the sIDall lymphocyte.

During

times of increased demand for myeloid or lymphoid element s these small round. cell s m2'y be found increB sed
in number in 8.ssociBtion with the more mature cells of
the respective streins.

Their studies differentiate

this primitive stem cell from the lymphocyte, which
they observed to develop into other definitive forms.
Numerous authors have taken sides with either one or
the other hypotheses.
our

pre~ent

l'[ay it suffice to say, that

information justifies both the position

taken by those who h8ve contended thl?t the "lymphocytelike" cells may differentiate into otherspeclfic definitive cell types, Bnd
of such a transformation.

thos~

who have seen no evidence

Those who have used the super-

avi,tal and fixed techniques extensively together feel
that the early precursors of the Hlymphoc3tt"B cycle, the
lymphobj..asts, me.y be distinguished from the "primitive
stem celi lt of the whites and also from the myelobllClst
Bnd monoble st. (34)

They claim th8.t the lymphobla st s

have a relativelY deeper basophilia, larger rod shaped
mitochondria, and fewer nucleoli (one or two) than do
the leucoblasts of the other two strains of white cells.
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Nei ther hypothesis may be considered

fl.8

mutua.lly ex-

eluding the other, but rather the difference seems to
be a. question of interpreting just where, if at all,
specificity begins and reversible dedifferentiation
becomes impossible.

The above diagram by Sebin (35) expresses very com....
pletely certain
the granulocyte.

c~iteria

in the maturation process of

On this chart matur8tion is represent-

ed as a series of varying factors, constantly changing.
In some levels, the factors may increase together, in
others, some may increase while others decrease.
Sabin gives the following explanation of the chart.
Level I is best studied in a completely aplastic adult
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bone marrow from w'hich 8.cti ve marrow is readily end
quickly regenerated. (31)

In such a Duiescent marrow,

only three types of cells can be seen:
lium,. and reticulum.

fat, endothe-

Of these three, the fat is but

accessory to blood formation.

Evidence indicates tha.t

the red cells regenerate from the endothelium, while
the white cells regenerate from the reticulum.
The reticular cells Bre ea.sl1y found because they
are the only cells lying between the fat cells along
the reticu18r framework.

The nuclie he.ve so Ii ttle

chroma tin as to make them scarcely more ba sophilic tha.n
the cytoplasm.

These cells Bre probably as close to

primitive embryonic mensenchyme as occurs in the adult
animal.

MaTI'cry (36) describes the reticular cells as

a type less differentiated than the fibroblast but also
says they may differentiate into a fibroblast.

These

reticular cells were described by Cunningham and others

(37) as to there charecterietics and relation to the
origin of the white blood cells.

These cells can always

be found in bone marrow, lymph glands, a.nd spleen, and
have been reported along the blood vessels in connective
and brain tissues, and nervous tissues in general. (38)
In reSeneratingvmarrow, this primitive reticular cell,
with repeated divisions, gives rise to a primitive free
cell.

In this process, a few mitochondria are elaborated

in the cytoplasm and basophilia gradually develops. (37)
i
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Finally, as' the basophilia of the cytoplasma and the
numbers of the mitochondria reach a maximum the cell
becomes.a myeloblest.

It is this small primitive free

cell which has caused so much confusion in hematology
because of its similarity morphologicB.lly to the small
mBture lymphocyte'.
The classific2tion of the myelocytes, Level II,
by the number of granules was introduced by Cunningha.m,
Sabin, Austrian, pnd Doan. (39)
derived from the myeloblast.

Myelocyte type A is

It is of maximum baso-

philia and mitochondria but contains
ulation.

13.

minimum of

gr~m

...

Type B represents the stage during which gran-

ulation is increasing, while Type Cis the stage at which
granulF-ltion reaches its maximum.

The conventional class-

ification of Level II is promylocyte and myelocyte depending on the changing chemistry of the granules.

At

the end of Level I I be sophilia and cell di vi si on ces.ses
while amoeboid activity is i?itiated.

The cell first

showing a.moeboid movement is termed a metamyelooyte.
The third level, marking the end of maturation, is
characterized by cells of 8 pproxim~ltely uniform size
and content of specific granule.tion.
functional maturity.
vi sion he s c ea sed.

These factors mean

The nuclei fragr:J.ent, but cell diThe leucocytes become more ma.ture

in the circulating blOOd and finally pass into the
Arneth pattern involving muclear changes and finally in-
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to the non-motile, fragile forms.
Granulopoesis occurs in the more vascular

8~reas

and develops around the patent sinuses a.nd moves toward
their borders as the cells become more mature;

in con-

trast to the red cells "';thich develop in the area of the
closed sinuses, the more mature cells moving toward the
center of the sinusoid.
With the concept in mind that bone marrow as an .
organ is the place where two types of cells are made,
that it holds a large store of each strain almost ready
for delivery, a.nd that its store of immature forms is
small in numbers, but of exceedingly high potentiality
toward multiplication, growth, and maturation, the
question of the mecha.nism whereby a normal structure in
both the marrow and blood is maintained becomes the major problem of hematology.
Doan (40) and others have shown that vlhatever controls the proportion of collapsed capillaries to open
sinuses is an important factor in the regulation of the
proportion of red cells to myeloid elements in the marrow, the ratio being directly proportional.

This mech-

anism, they claim, involves both vasomoter a nd chemical
control.

Doan And Zerfas (41) give the following rnye-

loid--erythroid ratios:

80:5,

80:4,

and 71:13.

Sa.bin

(35) after analyzing the works of Krogh, Hooker, Rich8rds,
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Rich 8.nd others, stetes that it is not clear what part
<

the v8.somote!' nerves and what pert chemical stimulB.tion
of the local endothelium plays in collapsing the sinuses.
Besides the factors controlling the mechanism of
maturation, one must also consider the

mech~Jnism

of de ...

Sabin (35) finds

livery of the cells to the circulation.

that for a.dmission of cells into the circulation two
structures are involved:

the endothelial walls of the

sinuses, and the blood cells themselves.

The granulo-

cytes, as maturation progresses tend to become massed
against the capillary wall and eventually bend it inward unt il finally the tense
two endothelial cells.

membr~me

ruptures between

The number of leucocytes in the

blQod is dependent upon two factors:

first, the rAte

of maturation, and secondly, the rete of delivery into
the blood.

Sabin (35) calls the second factor, a chemede~ignates BS

tactic factor (0) while the former she

a

Doan and others (40) have ad-

maturation factor (V}.

minstered inactlvRted typhoid b8cilJ i to a rB.bbi t and
followed the blood

the stages of leucocytosis.

th~ough

The marrow was finally found :entirely depleted of myelocytes C and E Bnd reduced to a low level of amydlocytes A and myeloblasts.

~'32bin

(35) expresses their

results as a condition due to a chemotactic factor
minus a matur8tion element.

This concept of leucocy-

tosis and leucopenia postulates the infecting organism
as introducing both

B

chemotactic and

B

maturation fa-

ctor when leucocytosis results and chemotactic factor
8"10ne when B leucopenia follows B. temporary leucocytosis.
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An important contribution on the subject of chemotaxis was introduced in 1928 by Doan, Zerfas, Warren
and Ames (42) in a study of the effect of large doses
of mucleic a.cid.

Their etudj.es of t he bone marrow show-

ed cle8rly a chemotactic effect of the nucleic acid,
with the massing of leucocytes around the patent sinusoids" a marked diapedesis into the vessels, 8nd the
vacant areas of the marrow from which the granulocytes
had been dr8wn.

They then found that the granulocytes

could be called from the marrow by
of nucLeic acid, adenine

~md

the~plit

products

gU8nine nucleotide.

this they conclude that nucleic apid

From

and its deriva-

tives are important physiological factors in the chemotactic action, and thpt the showers of non~motile,
•
~ragile leucocytes in the circulating blood mar give a
rythmic discharge of such prOducts into the circulation
pnd so be responsible for the rythmic diseh8rge of leucocytes from the bone marrow whi.ch actuelly occurs
normally.
However, of the maturation factor there is but little
known.

The physiological maturation factors for white

cells are not known, but Sa.'bin (35) has postulated that
,those bacteria th8t produce a sustained leucocytosis
introduce such a factor for they produce an increased
ai vision, growth, snd maturing of the less mature myelocytes in the marrow far beyond normal counts.

Novy
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and Eppler (43) consider tht:lt the

m~:tturation

factor

comes from altered body protiens and not from factors
introduced into the bOdy from the outside.
Certainly the modern aspect of the problem involves
a shift in emphasis from the morphologica.l study to the
investigation of the chemical maturation factors.

These

chemical fa.ctors should be sought in bacteria known to
affect blood cells, in certain organ extracts, as well
as in specific dietary fa.ctors, some of which may be
vi ta.mines.

Such a knowledge of these

should unravel the conditions which

~emical

underl~e

factors

abnormal

changes in mechanism, for example, granulocytopenia.
ETIOLOGY

Since the first report of Schultz (3) in Germany
thirteen years· ago and the report of Lovett (44) in the
United States but eleven years ago, cases of granulocytopenia reported have been constantly on the increase
until in 1934

Kr~lcke

and Parker (45) collected reports

of 473 Cases from the American and Cana.dian literature.
With this increasing frequence, many investigators have
directed their efforts toward the solution of the etiologic tactors.

The following presents a review of the

work which has been done in this field.
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1EOGRAPHIC DISTRIBUTION:

Parker and Kracke (45)

heve collected from literature reports of 473 cases
from 1922 to 1932 inclusive.

They report an increasing

number of cases each year probably because of the larger
number of cases and its more widespread recognition.
During this same period there have been reported Borne
350 cases in GGrma.ny, 100 cases in France and but 6 cases
in England.

Dennis, in a personal communication with

Kracke (45) reported 2 cases observed.in Beirut, Syria
and states the physicie.ns from Palestine and Eygpt had
seen cases.

The rarity of the disease in England is sig-

nificant and will be referred to le.ter.

Granu1openit:l

seems to occur chiefly in the United states and Germany.
AGE, SEX, and RACE:

Fitz-Hugh and Comroe (46) in

a series of 18 cases find the average age to be 48.1 years,
the youngest 19 and the oldest 78.

Madison and Quier

(14) in a ceries of 14 cases, the youngest 22 !'>nd the
oldest 80, give an average age of 51 years.

Kracke and

Parker (45); from their report of 473 cases, find the
average age to be between 40 and 50.

These authors find

thet the disease occurs in a retio of two females to one
male.

Kracke (45) reports only 8 colored cases to 465

whites.

None of the authors report any sea.sonal variati ons.

OCCUPA'IlION:
ing statement:

Pl?rker and Kra.cke (45) make the followII

It is a striking fact thctt

gr~mulopenia

is more prevalent among physiCians and their relative$,
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nurses, hospital employees, and medical students than
in any other group of people.

Based on the 1930 popu-

lation census of the United Sptes, it occurs 50 times
more frequently in physicians than in tea,chers .11
Me.dison and Squier (14), Stelhorn and Amolsch (47),
Harkins (9), and Conner and associates at the Mayo
Clinic

(48) and others who have made a study of the

di sease (46), he.ve all ffietde the remarkable observation
thet many of the patients were members of the medical
or allied professions, or were relatives or friends of
physicians.

These men have also repeatedly called at-

tention to the fact tbP t this disease occurs for the
most part in the better class of our people.
BACTERIA:

Lovett (44) in 1924, noted in her case

the presence of mouth ulcers infected with B. pyocya.neus
and at once suspected this organism

~tS

etiologic.

S~e

injected numerous la.boratory animals but failed to produce the condl tion.

Windham (49), Keeney (50), s.nd

others have made similar observations.

'rhese findings

have led many to suspect it as an etiologic factor but
up to t he present time efforts to reproduce the disease
in laboratory a.nimals with it, has been unsuce-essful.
Kracke and Parker (45), from their report of 473
cS.ses, find 74 of the cases to have positive blood cultures.

Among the infecting organism were 26 different
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types~

which illustrates the wide variety of infecting

organi sms.

Fr'ied and Dameehek (5), reported the experi ...

mental production of granulocytopenie" in rabbits by the
intravenous injection of Salmonella Suipestifer.

How-

ever they failed to produce a sustained and prolonged
depression of the leucocyte count but only

ft

temporary

depression, which has well been demonstrated to follow
the injection of (3,ny killed organisms or other matter
in a finely divided state • (23)
There are many reports in literature concerning the
efforts of various investigators to reproduce the disease
in laboratory animals with organisms th2t have been iso ....
la.ted from their respective pe.tients, but all this work
has been unsuccessful.

Piersol and Steinfield (23),

injected intravenously into rabbits inactivated cultures,
Berkefeld filtrates, and supernatant fluids of cultures
of many organisms and failed to reproduce the conditioh.
They called a.ttention also, to the fact that a temporary
leucopenia may be produced by the injection of peptones
t'md a large number of other protiens.
Since the works of Ruedeger (52) in 1905, Nakayama

(53) in 1920,

a~d

Gay and Dram (54) in 1931, it has been

known that continued absopption

ci:

toxins from s1 tes of

focal infections has the property of destoy1ng white
blood cells, particularly granUlocytes.

To this toxin

they gave the name of leuco6idin •. Dennis (55), was par-
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ticularly impressed by their findings and in 1923 reported a series of experiments in rabbits which show
great promise.

From Dennis' study of other cases report-

ed in literature, he learned

th~t

the bacteria most

often present were Streptococci and Staphlococci.

He

felt that if via,.ble cultures of such orga,nisms could be
enclosed in

/3,

membrane which would permit egress of only

the soluble products of bacterial metabolism, leucocidins,
thet experimental agranulocytosis could be induced.

He

brought about this condition by injecting a living eighteen hour culture of organisms into plOtrchment capsules
and sealing the punctures with celloidin.

After a thor-

ough soakir;tg in 70 percent alcohol, these capsules were
introduced into the 8.bdomina,1 oa.vi ties of twenty rabbits,
through small incision made under aseptic conditions.
Two rabbi ts received capsules of sterile broth a.s controIs and were entirely negative.

Staphlococcus aureus,

streptococci hemolyticuB, Streptococci viridins, and B.
proteus asiaticus were sepa.rately used" all producing
granulopenia.

strep. viridins produced, in two animals,

a syndrome practically identics.l with acute clinica,l
granulocytopenia, termlna.ting fatally.

From this, Dennis

suggests that granulocytopenia. in man is due to the action of leucocidin rather than a specific microorgan\

ism.
The injection of dead bacteria in the course of
vaccination has been suggested as a possible cause.
Bromberg and :Murphy (56), Kre.cke (57), and others have
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reported typ:1,cal cases following typhoid vaccina.tion.
However, these cases had received consideretble previous
meo.ica tion.
GLANDULAR DYSFUNCTION:

The influence of the en-

docrine glands on the output of both granulocytes and
eryth;rocytes has been studied considera.bly and ba s long
been suspected •. Jaffe (58), studied a patient with gen. eraliz,ed infiltration of lymphadenoma which included invasion and destruction of the adrenal cortex with the
patient finally dying with a typical granulopenia.

He

infers from tl1is thc'3t the granulopenia was due to a cortical adreni3.1.

insufficiency.

Britton and Corey (59),

ha.ve reported that a.drenal insufficiency in cat s resul ted in a marked degree of neutropenia with t he return
of the granulocytic level.to normal following the administration of cortico-adremtl extract.
hO\~iever

They did not

produce the typical granulopenic syndrome.

Kunde

and others (60) have noted the production of hypoplastic
and aplastic bone marrow 'in thyroidectomized rabbits.
Hubble (60) postulates that bone marrow depression may
be caused by a pi tui tary basophilic insufficiency, a.nd
he states th t there is much evidence to indicate that
granulopenia may be caused by cortico-adrenal dysfunction.
Evidence accumula.ted indic8tes tha. t the ductless glands
ma.y pla.y a pa.rt in the etiology, however, this concept
will have to await further ·confirmation.
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RADIATION:

Excessive exposure to radiation has

been suspected as a possible etiologic factor although
it is sometimes used in minute quantities in the treatment of the disease. (45)
ALLERGY:

A few authors believe that gra.nulocyto-

penia may be a form of allergy in which the 'bone marrow
is the point of least resistance.

Shilling (19) pro-

duced a blood picture similar to tha.t of granulocytopenia_
experimentally in a.naphylaxis, so that he thinks it may
be an anaphylactic reaction instead of an individual
disease.

'rhe c a.se s of Bromberg and Murphy (56), as well

as Kracke (57), who received typhoid v!9.ccine, have already been mentioned.

It is possible these cases may

have resulted from an overwhelming reaction to foreign
protein in a sensitive subject, however it is interesting to note that in a.ll these cases there had been previous

dr~

therapy.

CHEMOTACITIC.AND MATURATION FACTORS:

It has been

previously mentioned that two different processes must
be considered concerning the mechanism to maintain production and destruction of granulocytes at a constant
level(35):

(1) the mechanism of delivery of cells to

the circulation and (2) the mechanism of maturation.
Fitz-Hugh end Krumbna.ar (62), from autopsy study of the
bone marrow are of the opinion tha.t there mB.y be a definite hYperplasia up to the myelocytic level but that
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matur8tion ce8.ses at that pOint.

Rosenthal (65) and

Kracke (64) have independently reported cases in which
there was a definite hyperplastic bone marrow at sternal
puncture at a time when there was a peripheral neutropenia.

Beck's conception of such c's.sis is as follows:

In typical cases of malignant neutropenia with myeloid
aplasia, the part of the bone ma.rrow that manufa.ctures
the granular leUkocytes, level I, has ceased to function,
or nearly so.

The life of the granular cells of the

blood stream being but from 3 to 5 days, when level II
and III a.re exhausted, the granulocytes of the blood
strea. m will tota.lly disappear in from 3 to 5 days there ...
after.

There is little evidence tp...a t the granulocytes

B.re abnormally destroyed in the blood stream.

The bulk

of the evidence pOints to the fact that the primary
lesion, sO far as is known is the granulopoetic area of
the bone marrow, and that this condition precedes the
c1inica.l symptoms and loca.l infections.

She reasons

that the primary lesion is not in the bone marrow but
in the organ or tissue which give rise to the substance
(maturation factor) that keeps the gra..TIulocytes to a
normal blood level or keeps the destruction and production at a constant level.

She points out that the text

book picture of pernicious anemiB. can very aptly be substituted for that of malignant neutropenia and as a ma-
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turation factor for erythropoesis has been found. so
it rem/olins but to find the maturati on factor for granulocytes.

She suggests that a chemical analysis of

bacteria known to produce a leucocytosis might let:td to
a solution but that it seems more 10gica.l to seBrch
within the bocly for the particular organ extJ:'act reguleting granulopoesis.
The other group

of patients showing peripheral

neutropenia with slight hypoplasia; normal, moderate,
or marked hyperplasia of the myeloid tissue, S1:1e considers as due to a lack

~

the chemotactic factor.

The cells my be growing and ma.turing but are net being
. called to the circulating-blood.

The normal stimulus

for calling the granulocytes from the marrow to the circulating bood has been shown by experimental work (42)
to be the liberated products (nucliec acid, adenine,
guanine, and etc), from disentegrating granulocytes in
the blood streB.m.

This theory, she points out, could

account for failures in the treatment of

pa~tients

with

nucleotides who clinically were similar to those who recovered under such trea.tment.

If the maturation factor

is absent, a chetnotactic factor would be of Ii ttle value.
CHEMICALS:

It has long been known that various

chemicals wil], depress the bone lJI'rrow function, resulting in partial or complete inhibition of one or all cel-
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lu19r types.

Farley (10). gives Labbe e.nd Langlois the

credit for describing the first case of depression of
the bone marrow function following the use of arsphenamine.

This was in 1919, just nine years Ffter the in-

troduction of salvarsan and neosalvarsan by Ehrlich.
Since ths.t date, up to and including 1929, Farley collected 39 such cases from literature.
died and 16 recovered.

Of these, 23 patients

'rhe symptons varied from those

of purpura hemorrhagic a to those of severe aplastic

2-

nemie, and malignpnt neutropenia, depending on whether
the principal effect was on the granulopoetic, megakaryopoetic, or erythropoetic tissues or on all of these
combined.

Farley summarizes his cases·in saying that

it 5eems likely that the direct cause is the disintegration, in vivo, of the arsphenamines

80

that a. benzol-

like action ta.kes place, end suggests tJ:1..at the rarity
of occurrence may be explained on a preceding weakness
of the hemopoetic apparatus of the individual.
Selling (65) in 1910 repqrted three cases of benzene pOisoning, cher8cterized by granulocytopenia and
complicated by purpura

~md

ing in a rubber factory.

hemmorhages, in girls workOne of these girls had Quit

her work long before, which illustrates the delayed
and cumulstive effects <;>f the Chemical.

In 1916 Selling

(66), experimented with benzene by subcutaneous injections into rabbits and demonstrated the production of
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leukopenia '.l1i thout an erythropenia.
benzene pOisoning has become

~

fairly well recognized

syndrome to the medical profession
ports of cases.

Since 1910,

with

num~rous

re-

These cases for the most part show a

depression of more than one of the bone marrow functions.
In 1932 KrEtcke (67)

Wf'S

able toproduce a selective act-

ivity on the granulopoetlc tissues without disturbing
the erythroctic and

thrombocytic element.s.

There have been numerous ceses reported from France
followi~g

the injections of

certain~eparations

of gold.

(45)
'rhe fact thet typical granulopenia C8.n be produced
by gold preparations, by arsphena.mine. and by coal tar
derivities (to be substantiated later), all of which
contain a bonzene ring is evidence that all of these
SUbstances must have some common factor which manifests
a selective activity on the granulopoetic tissue.

In

following this hypothesis it may be well to outline
briefly the works of Kracke and Parker (45), in which
they studied the relation of drug therapy to granulopenia.
From reports to a questionaire, they gathered that
there exists almost a direct proportion between the in,cidence of granulopenia Bnd the incidence of usage of
drugs containing the benzamine (benzene amide group)
group, ie .• , 3 out of 4 nurses or 3 out of· 5 physiCians
but only lout of 4 laymen and lout of 8 negroes will
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select a c08.1

t~u·

drug for use as an an81gesic.

They

feel th&t the prevBlence of the dlsease in the United
States and Germany parallels the usage of coal tar
drugs, while in Eng1a.nd these d rugs are used but Ii ttle.
These drugs have been introduced only in the last ten
or twelve year period which corresponds to the period
of granulopenia.
It is there opinion that it 1s not the direct a,ction
of benzene that produces the depressant action upon the
bone marrow, but the a.ction of one of the oxids.tion products of benzene.

In support of this contenti6n, they

injected rabbits SUbcutaneously with mixtures of equal
parts benzene and olive oil a nd upon I:ma.lysis 18 hours
later found only traces of benzene but considerable phenol and catechol.
to be absent.

Control animals showed these substances

?urthermore, the bone marrow of the in-

jected a.nimels was analyzed and showed the presence of
both phenol and catechol but no trace of benzene.

Con-

trol animals were negative in this case also.
The oxidation of hydoquinone or c8.techo! to

p~u"a

quinone and orthoquinone respectively can easily be carried out both in vivo and in vitro.

In vitro the re-

action is activated by the enzyme phenolase which is
present in the leucocyte.

This progressive oxidation

is illustrated on the accompanying chart beginning with
the original substance, benzene.
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Oxidation beyond this point would break the ring
end so reduce the serious toxic action.

The relation

of coal tar deri vi ties to granulopenia, has previously
been mentioned.

These d rugs all have substituted a.mine

groups on the benzene ring which make them primary a.mines
and are designated as IIbenzamine drugs H •

The benzamine

drugs include neoarsphenamine, arsphenamine. acetanilid,
phenacetine, and amidopyrine.
can be studied from the chart.

There structual formula
Tl::e amine group set s

these benzamine drugs apart from other coal tar derivetiE'S, such a.s aspirin which do not heve such a group,
because of the much greeter ease under which oxidation
c!:m occur.

Kracke end Parker have worked out the possible

oxidation products of the benzamine drugs in an B"ttempt
to arrive at pn end-product

com~on

to all.

The reactions

are logical and sound ':chemically but hlghly theoretical
physiologically in th8t they have not been proved to occur
in vivo.

The progressive oxidation products of these com...

pounds a. re illustrB.ted on the accompanying chart.

The ox-

idation of phenacetine and acetanilid to para-amino-phenol
has been established in vivo.
Voegtlin (68) has well established that arsphenamine
or neoarsphenamine, ,,'{hen administered intravenously, is
readily decomposed by breakage of the double bond with
the resulting formation of two molecules of arsenoxide.
Kracke and P8crker theorizes on their furthsr oxidation.
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Kracke and Parker have been able to produce mild
and severe grades of granulopenia, experimentally by use
of the oxidation products in only an oecasiont::Ll animal.
However, they amend this f8ct by saying that one must
rernember thqt not all laboratory animals have an inferior bone marrow and the sa,me s1 tUB.tion may exist in the
rabbi t 8,S in the human, namely, only an occ8.sional human
being develops gra.nulopenia while many thousand of individuals have taken benzamine drugs indiscriminately
and have shown no depression of the bone 'xaJ:'row •
And so one may conclude that the etiology of
locytopenia is still unknown.

But that there has been

much promising work done in the p8.st few years, the most
outstanding of which includes Dennis' work on leucidins,
Beck's work on the maturation and chemotactic factors,
and last but probably the most importa.nt, that of Kracke
and Parker on the benzamine drugs.

PATHOLOGY
The pa.thology of the di$e8se is in dispute.

!.~uch

of this confusion arises from failure on the pErt of many
even to attempt the differentla.tion, either clinically
or pathologically, of the verious conditions giving rise
to the striking but far
of extreme granulopeni D

from pathognomonic sign that
•

Confusion also arises from too

I
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great reli9nce being placed on the interpretetion of
stained emeers taken from the bone marrow.

From smears

of the bone marrow one gets absolutely no idea of the
number or arrangement of the cells B.nd upon such factors,
as well as upon the nature of the individual cells, the
diagnosis of Bny marrow lesion must be based.

Custer(69J,

Peabody (70), and Jl:lckson and P2rker (71) have all expressed this seme opinion.

Finally, the normal variations

of cellularity from bone to bone must be recognized so
thpt one will not make the mistake of pronouncing the
bone ma.rrow ttaplastic ll from an examin8tion of the tibia
alone. (71)
Roberts and KrE'cke (72) say that there is a.n unanim1 ty of opinion that the essential pa.thology of granulo ....
cytopenia is a marked and practically complete hypoplasia
of the myelocytic tissues.

In one of their cases, sternal

puncture and smear showed a marrow entirely devoid of granular cells of any type, including even myeloblBsts.

Dodd

and Wilk1nson (73) state that the bone marrow is aplastic,
but their case wa s a colored girl of eleven years w-1 th he-reditary syphilis who after treatment with sulpharsphenAmine developed extreme leukopen1e.

This condition could

hardly be called true idiopathic grsnulocytopenia.
often thought thet the marrow might be aplastic.

Schultz
,
However,

Leon (74) who described the marrow in Schultz's CBses,
merely says that there were neither
m

TIE

ture neutrophils nor
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myelocytes to be found a.nd that the femur was partly
red, partly fatty.

In the case under consideration,

only the tibia or mid femur was examined so is it any
wonder that the histological picture of the disease is
regarded as confusing.
Jaffe (75) found a bone marrow rather more cellular
than normal with signs of marked degeneration in the granules of the myelocytes.

He believed the ma.jori ty of the

white ·cells to be myelocytes with a moderate or considera.ble number of pIa sma cells and lymphocytes.
cytes found in norma.l or increased numbers.

Megaka.ryoF'i tz,-Hmgh

and Krumbh[l.ar (62) as well as Jackson and Pa.rker (71),
postulate a maturation arrest at the stem cell stage
wi th the added possibility of Em end stage which might
be regarded as aplastic.
Jackson and Parker (71), after an examination of
the marrow from twenty-five cases dying in various stages
of what seemed clinically and hematologically to be class10al agranulocytosis, make the following generalizations.
They found the marrow of the vertebrae, ribs, sternum and
mid femur essentia. lly the same.
was usually norma.l.

Rarely the femur remained fatt.y as

in the normal a.dult.
death occurred too
peripherally.

'rhe degree of cellularity

They thought that in such instances

80 on

for the marrowl::wti vi ty to spread

In some sternal and vertebral merrows,

particularly in patients dying later in the

d~sease,

a
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certain amount ofbypoplasia existed.

On the other hand

in the fulminating cases the marrow was perhaps
rich in cells.

unusu~tlly

The degree of-cellularity, however, varied

but little and they think this fElct to be of minor importThey found little or no cHsturbance in the red

ance.

cell series.

Erythroblats, normoblasts and nuclepted red

cells occurred in nortr.al or slightly increased numbers
and showed no abnormal features.

The megakaryocytes aslo

"{{ere found in the usua.l numbers and histologically eppeared perfectly normal.
wi th the la.tter.

Rotter (76) ,and Jaffe (75) agree

However Robert s and Kracke (72) are of

the opinionthpt the hemorrhagic tendency which they regard as a very common sympton of the disease may be traced
to a marrow disfunction involving megakaryocytes and a decrea se of platelet formation.
Jackson end

Fark~r

report that the most marked bone

marrow changes naturally occurred in the cells of the grl:m-

.

ular series.

No mature granulocytes either neutrophils

or eosinophils, were found in any marrow, nor were there
any true myelocytes.
cyte.

Very rarely they report a promyele-

Practically every cell belonging to the granular

series was a stem cell.

Occasionally, in patients dead

from pulmonary embolus, sepsis, or some other complication
they found myelocytes, metamyelocytes, and young neutrophils in profusion throughout the bone ID8rrow which weS
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generally hyperplastic.

But in those cases which, at

the time of death, showed extreme leulopenia a.nd granulopenia, only stem cells, plasma cells or lymphocytes
"If,rere found.

Fitz-Hugh and. Krumbhear (62) contrue this

fact to evic.ence a maturation arrest rather tha.n

B.

ure of delivery of cells into the blood stream.

Jackson

and Parker agree with this theory.

fail-

The parent cells were

often seen in active mitosis but further maturation was
denied.
In those patients who survived the ravages of infection for a considerable period (eight to twenty days) the
bone marrow picture was somewhat different.
found to be relatively hypopls.stic.

It was then

(j'radual1y as the

diease progressed the stem cells dimished in number and
their place was taken by lymphocytes a,nd plasma cells
8nd in cases dying

8S

lete as the fifteenth day after

the apparent onset of the disease these cells constituted
virtually the only white cells in the marrow.

Rotter

(76) is in egreeence with t he t?,bove findings.

Pepper

(77)' and Jaffe (75) stress the gegenerative changes occurring'in the marrow.

However other

autho~s

(71) are

of the opinion that when such changes occur they are the
result of bacterial invasion of the bone marrow itself.
Beck (1) states that infection of the bone marrow in
benign and malignant neutropenia has never been demonstrated except in termin8.1 septice:nia.•

However she admits
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thRt the 'Nork along t hi s line ha s not been exhaustive
and further research may show this to be

Fl.

greet factor,

especially in fulminating cases.
The reaction in the spleen Beck (1) found to depend
on the predominance of toxic or septic symptoms.

In cases

observed at autopsy, asplenlC tumor, partly of splenic
character, was disclosed in some cases.

Enlargement of

the spleen in some cases she states as due to a great

in~

crea se in the reticulo-end-thelia.l cells, which outnumber
the lymphoid cells.

The lymph follicles Bre not prominent

on the cut surfa.ce.

Microscopically, the sinuses are fill-

ed with erythrocytes, proliferating reticulo-endothelial
cells and lymphoid cells.

'fhe liver, Beck· seys, ":nay be

somewhat enlarged and show cloudly swelling.

croscop-

iC8l1y, some cRset" have shown fatty degeneration, Bnd occasionally

s~Bll

multiple foci of necrosis.

incre8.se in Kupffer's cells,
bile capillaries and bile

There is an

'rhere B.re bile cs sts .in the

pig~ent

in the hepatic cells.

Sometimes there are interstitial lymphatiC infiltrations.
Hueper and Gerrison (79) describe the pethologicchRnges in the lymph nodes

B.S

follovrs:

The submaxillary,

cervical, peribronchial and mes6Bteric lymph nodes are in
general enlarged and they sometimes contain hemorrhages.
]j~icr08copic

licles;

examinl:<tion reveals atrophy of the lymph fol-

there a re no young lymphocytes in the germinal

centers, only mature lymphocytes being present.

There

is a proliferation of the reticula-endothelial cells.
SYMPTOMS
A great many pe.tients give a history of weakness
or lack of vitality for varying periods before the onset of the condition, especially in the chronic recurring
cases.

Some natients state that there wps a lack of en-

ergy for ye8.rs and a marked weakness for a few weeks or
months before the onset of t he acute symptoms.

On the

other hand, neutropenia occurs in some patients who have
alwa.ys been well 8.nd who were active physically and mentally until the sudden onset. (1)
Beck (1) says that the usual mode of onset is marked by fever, chill 1:md sore throat, which may be sudden
or gradual.

To these may be added hea.dache, marked pal-

pitation with a tumultus heart beat, general aching,
drowsiness and occasionally delirium.

Some patients are

nauseated end vomit, and, as a rule, there is dysphagia.
There is an,_offensive, fetid odor to the bree.th, and
the tongue is often h3avily coated.
1'he patients a.re wilted in appearance;
is pale, but the mucous membranes

e~re

the skin

of goad color.

The weakness, marked prostration end toxic appearance
are out of all proportion to the few physical signs.
Jaundice is rare in typical cases.
may be enlarged.

The liver and spleen

The patients are characterized by weak-

ness, easy fatigue, drowsiness and tendency to infection,

especially in the oral cBvity.

Beck states tb.t there

is evidence that just mere lack of neutrophile will
CBuse euch symptoms as fever, wea.kness, inertia and mentel and physical collppse.

Roberts and Kra.ck (72) found

that complaints of weakness, exhaustion 8.nd fatigue were
tWice as frequent in the neutropenic patients as in those
showing a normal white cell count.

Furthermore, they

found that the severity of the symptoms paralleled to a
reme.rkable extent the degree of neutropenia found.

The

fulminating cases are rapid in progress, with a oomatose
concH tion usually preceding death.

The di sease may last

from three da.ys to three months, in rare cases
of years, and end with death or with recovery_

8.

number
The benign

group usually correspond to the fatal group of cases as
far as the early symptoms 8re concerned.
Jackson and Parker (71) point out that the fever has
nothing characteristic about it and most authors agree
with this.

As a general rule the temperature reaches a

maximum of 103 0 or 104 0 F.
even 107 0 F.

Ra.rely it may rise to 106 0 or

In some pl';ltients only a very moderate hyper-

pyrexia is the rule.

A steady, high, unremitting temper-

ature is of extremely grave prognostic import.
The local lesions seen in bEnign and malignant neutropenia usually occur on the mucous membrenes, more rarely
on the skin.

Lesions of the mucous membranes when present,

are localized mainly in the mouth and involve various
structures, such as the gums, tonsils, soft pa.late, lips,
pharFnx and .buccal mucous surface.

Yore rarely the nose,

uterus, vagina, rectum, anus and skin are invovled.
cal leeions may also occur any place along the

Lo-

ga~tro

intestinal tract or in the lungs and the symptoms are

8.C-

cording to the areas involved.
Owing to the absence of neutrophils there is none
of the usual inflammatory reactions about the ulcerstions.
But a peculiar brawny edema

~aj

be most extensive and

in the throat constitutes a grave menace to the patient's
life.

This €~dema., as stressed by Jackeon and P!',rker (71)

may be so great and so extensive as to preclude the possibility of swallowing and render breathing well-nigh impossible
There may be regiona.l adenopa.thy with nee'rosis and
sloughing of the overlying tissues and skin.

The tonsils,

when involved, have in some case's sloughed away.
grene Bud consequent sloughing may occur:

Gan-

this is par ....

ticularly dangerous event when it occurs in the gastrointestinal tract.

Two patients in the series of Jackson

and Pa.rker (71) died from rupture of a necrot ic intestine.
In one the blood picture had tHready become norma.l too
late, however, to be of avail.
The classical clinical description given above is a-

greed upon by most authors some of which are Beck (1),
Jackson and Parker (71), Jackson H. Jr., (79) Baldridge
a.nd Needles (16), Ka.stlin (7), DORn (80), a.nd Fitz,-Hugh
and Comroe (46) ..
In a series of 103 cases reported by Jackson and
P~rker

they

~ound

the following blood counts. (71)

The

white count was rarely as high as 2500 per cmm. and is
often 1000 or less.

Frequently it is in the hundreds.

'::'hirty hF.td white counts less than 500, twenty-eight had
white counts between 500 and 1000, thirty-eight hRd white
counts between 1000 and 2000, and only seven had white
counts of between 2000 and 3000.
treme grade was the rule.

Neutropenia of an ex-

Only seven of their cases

showed neutrophils of over 5 per cent at the height of
the disease.
sent.

Eosinophile were

I'

ather consistently ab-

Such neutrophils as remained were old end often

degenerated.

The majority of the white cells present

were lymphocytes, for the most part of the e.dul t type.
Most authori ties agree that in the t'rue di sea se
there is little or no material alterRtion of the red
blood cell picture, or 8.ny notable diminution of the
platelets. (.7), (76), (81), (82), (71) •. Aubertin and
Levy (83) find, on the other hand, a constant thrombopenia and Roberts and Kracke (84) believe that the platelets are markedly reduced.

Most authors pOint out that

such cases of reported thrombopenias are to be regarded as
an indication that some other disease, notably aplastic
anemia or acute leukemia, is under consideration.
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DIAGNOSIS
Neutropenia must be diagnosed early if the mortality is to be reduced.

There should be more critical

cytologic examinptions of the blood, as there is much
evidence in the literature that the neutropenia precedes all other symptoms.

To wait for the appearance

of sore mouth, sore throatJ fever and prostration is
only giving the army of orgc1nisms time for invasion.
Ifhe patient is usually ill from several days to several
weeksJ or perhaps months, before the acute stage in
many cases.

The symptoms and blood picture are as char-

acteristic as 'those occurring in pernicious anemia in
most typical c'ases.

The symptoms and blood picture have

already been referred to and will not be repeated at this
time.

The rule should be to follow up each case of con ...

tinued fever with frequent leukocyte and differential
counts.

If angina and fever are both absent and there

. only weakness, malaise, a.nd dra.wsiness, a frequent
leukocyte and differential count should be made.

The

diagnosis is made on the low total count end the reutropenia.

Burcky (5) goes so far as to say that the diag-

nosis of agranulocytosis can be definitely made only when
the white blood count is greatly reduced, usually below
1000 cells per cubic millimeter, and when the granulocytes

-.

are either completely absent or found in very emaIl numbers,
and usually abnormal in character.

The presence of such

symptoms as great prostration, necrotlc TImcous mem...
braneulceretlone, and high fever, he says, are very
important corroboratory flndi:ngs.
P:ZOG1\TOSIS

The prognosis of agranulocyts,is is
St 8

""
1
t es ourCKY

I r:- \

\~)

extre~fiely

grave",

in pn article published in 1935.

He

points out that before the use of the present theraphy
(nucleotides), the mortelity rp,nged between 80 and 90
per cent for first
thing~

~ttack

with recurrences the usual

nearly always terminating fatally.

Kastlin (7)

in 1927 gave the mortality as 95 per'cent.
Harkins (9) in 1931, reviewing the cases in literature, obtained a

~ortality

of 82 per cent.

In the same

year, Rosenthal 63 reported a mortality of 46.2 per cent
in a series of twelve "malignant ll and fourteen IIbenign ll
09 ses.

. The S8,me year Taus sig B.nd Schnoebelen (57) in a

review of 328 CBses found a

mo~tality

of 75 per cent in

CB ses without spec'ial therapy and mi scella.neous forms
of treatment;

63 per cent with trans:fi'usion; end 53 per

cent with Roentgen treatment..

With t he introduction of

nucleotide therapy the prognosis he's become more favorable.

Jackson and Parker (7l) in 1935 report a mortality

of 33 per cent in a series of 103 CBses receiving such
tree tment.

In ce ses presumably c'hle to d rug therapy, the

mortality is nearly 100 per cent with the continued use
of the drug in question. (14)
It is evident tha.t with the loss of immunity to bacteria, the loss of strength, the prostration of the ment8l function, the rising fever and the quick sepsis, that
death is ineviteble unless a new crop 6f granulocytes is
quickly restored to the blood stream.
difficult
falls.

8.S

This becomes more

the total white count and granulocyte count

The more favorable prognosis since 1927 can un-

doubtedly be attributed to two factors:

first, the earl-

ier diagnosis of the' disease, and secondly, the use of
nucleotides as a therepeutic measure.

The increaseing,

use of blood counts should cause the mortality rate to
continue to decrease.

TREATMENT
The treatment of any disease, t he pathogenesis and
na,ture of which is uncertain, is at best unsatisfactory
and more so when t he.t condition may be easily confused
with other pathologicql entities of a probl'lble different
fundament 131 nature.

Many mea,sures have been advocated to

combat granulocytopenia.

NGne is apparently specific.

Almost all authorities agree that the major problem is
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thset of restoring t he bone marrow to its norma.l B.ctlvity end thus raising the peripheral white count;

for

the 10s8 of leucocytes removes one of the body's greatest defenses against infection.

Without bone marrow

recovery, there can be no cure.
NON-SPECIJ:"IC 'rHERI1FY.

The injection of sterile

milk, turpentine, reticulin, metaphen, and formic acid,
in conceded by almost everybody to be useless.

Doan

(80) in 1932, found a mortality of 74 per cent in 178
patients receiving such treatment.

That one gets a

white cell response in normal patients by such therapy
is not the slightest reason for supposing the.t a similar
response should occur in granulocytopenie. where there
are no neutrophils in the bone marrow to call forth.
The probsble effect of such treatment in normal patients
is chemotactic end not an increase production of white
cells.

Doan (80) compiled mortHlity statistics on a

large group of patients which received vprious types of
treatment.

His figures are as follows:

THEHAPY
Untrel3ted
7\1iscelleneous therBpe:utic
measures
Arsphenamine
Blood Transfusion
Irradi9tion
Xucleotide

CASES

DEATHk3

:'1: ORTAL I'fY

;\~~any

;v.Ieeny

90

178
33
33
64
44

133
24

74 .
72
64
53
25

34
34

11

'J'he tb...ree most efficacious methods of treatment as

?0
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gathered from these s:tatistics would be blood tranai

fusion, irradiation and nucleotides.

Doan suggests

!

that these three ther,apeutic measures must have some
common fs.ctor which i,s the a.ctive principle,

He sup-

poses that nucleotide, is this specific princlple and
!

explains its presence in the follo.ving manner:
n~cleotide

blood transfusions,

In

is introduced in small

quantities in sOlutior (85) and formed by disentegration
of white cells.

In irradiation, he supposes that auto!

genous nucleotide is liberated by the destruction of in"'"
tact myeloid focii.

With this hypothesis in mind let

us review these more !specific treatments of granulocytopenia.
TRANSFUSION.

T!ransfusionof blood he s been endorsed

by many authors amongi which be ve been Hueber (86), Peper
I

(77), Fitz-Hugh B.nd Ciomroe (46), end Taussig (87).

With-

i

out question recoveri:es have follOWED. blood transfusions
,

but aside from this there is no evidence that transfusions heve a. stlmulatiing effect upon the bone ma.rrow.
Jackson and Parker (7!1), even go so fa.r as to state that
it is not an uncommon! experience to find the peripheral
whi te blood count lowier
after transfusion than before.
I
They state that the'

~ortality

in their series was the

same for the group rejcei ving both transfusions B.nd
pentnucleotide and

fOr

these receiving only pentnucleotide.
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In the last three Or f.our years the enthusiasm of the
efficacy of blood transfusions has been lost in the
greater enthusiasm for pentnuc1eotldes (71), (88), (89),
( 5) •

X-RAY.
cated

~y

Stimulating doses of X-ray have been advo-

many (89), (87),(90), (91).

Friedmann and

Elkeles treeted 43 cases with irradiat5.on with a mortality of 32 per cent.

Taussig and Schroebelen had a mor-

tality of 50 per cent in four cases.

Licklerstein treat-

ed 20 cases with improvement in seven but a year later
only two were ali ve--s mortali ty of 90 per cent.
(86) enthusia.stlcal1y recommends radiation.

Heuber-

Reznikoff

(92) has expressed the idea and Jackson and Parker agree

(71), that even small doses of X-ray tend to depress the
marro wand they point out that four or five days must
elapse before the effect s of any mature.tion element can
be detected in the peripheral blood.

It is usually

claim~

ed by advocetes of r8.diation that favorable changes occur
vdthin a few hours.

When such changes occur Jackson 8D;d

Farker 8.ttrlbute the rise as spontaneous, or, if actually
du~

to radiation, to a redistribution phenomenon rather

than a maturation factor.

Like tre.nsfusion, X-ray therapy

has come to be disapproved in the last few years.
LIVEH EX'l'RACT.
many,

Liver extract has been advocated by

F'ors.n (93), injected the

e(~uiv~;llent

of' 100 grams

of liver into the veins or muscel every 8 to 12 hours
until a definite rise in the white count
Four

C8

h~d

taken place.

ses were appa,rently successftllly treated.

ever, C':; ge shAll's (94)

C8.

How-

se fa iled to respond to six

vials of liver extract intravenously each day.

Four of

the pc,tients in Jackson and Parker l s (71) series received
liver extract

BS

well as pentnudleotide yet all died.

Silver-·(95) treated a case appa"rently due to dini trophenol without benificial results.

Eonsdorff (96) treat ...

eO. two cases with liver extract with recovery in both
instances.

However Parker (71)

poin~s

out that one case

vms probBbly a perniciOUS anemia and the other due to
nov8rsenobenzol and bismuth which when removed may have
been of considerable prognostic importance.

Walker (97)

stetes thet the value of liver therapy is doubtf'ul becp.use it is not known defini tely if it ha.s a stimulating
effect upon granulopoesis.

However he thinks it does

no harm, and in cases of anemia is beneficial.
NUCLEOTIDES.

liThe history of this remedy goes back

to the day s of frequent sep:::1i sand 'laudable I pUSH, sa.ys
Walker. (97)

Pus was easily obtained in those early

days, and from it nucleic acid was prepared, being so
called becs.use it .wa s believed to be chiefly derived from
the nuclei of leucocytes and other cells.

,

Later it was
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found that nucleic acids occur in combination with
various protiens in the form of nucleoprotiens.

By a

process of hydrolysis the purine bases adenine a.nd guanine
were isolated, and derived from these products was pentose
nucleotide, found to exist chiefly in the nuclei of living
cells.

In 19~4 Jackson (85) definitely demonstrated the

presence of pentose nucleotide in normal human blood.
In 1930 Reznikoff (98) advocated the use of adenine
sulphAte in the treatment of granulocytopenia..

In 1933

(99) he summarized the results in fifteen cases with

eleven recoveries.

He also treated eight

~ases

in which

the diagnosis was doubtful, ''!1th but one recovery, and
twelve C8.ses complicating other diseases,
coveries, a.nd these only temporery.
were conservatively optomistic.

'0t

i

th two re-

Hi s conclueions

The treatment with aden-

ine sulphate consists of dissolving one gram of the salt
by boiling two or three minutes in 30 to 40 cc of normal
saline solution, allowing to cool slightly, filtering
through a erne II adapter containing cotton to filter out
all undissolved crystals, and injecting intravenously
while still warm (105 0 to 1100F.).

This dose is to be

used three times a day for At least tb.ree days. (5)

The

drug is non-toxic, gives no disagreeable reaction, and
may be used in the presence of myocardial disease.
Inasmuch as it had been shown by Doan, Zerfas, Wa.rren
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and Ames (42) in 1928, that pentose nucleotide could
definitely raise-the peripheral white count in normal
animals, Jackson and his co-workers (100) decided to
try the effect of this sUbstance in those conditions
characterized by extreme leukopenia.

In 1931 they re ...

ported the results of such therapy in twenty eases of
granulocytopenia with fourteen recoveries.
they (101)

re~orted

In 1932

on 69 cases treated with pentose

nucleotide (iQcluding the original twenty) with a total
mortali ty of 26 per cent.
I

(71) have

sdd~d

of 103 cases

Since 1932 Jackson a.nd Parker

34 cases to t his series making a tota.l

\~ri th

a mortality of 33 Del' cent.

Only those

cases treated for less than 48 hours or those which died
of some entir,ly unrelsted disease were excluded.

They

have followedsll these cases to date (1935), including
all deaths in. their mortality figures.
Pentose ~ucleotide was introduced as "Nucleotide
K 96 ft , but is'now marketed under the trade name of
-

i

"Pentnucleotide ll •
!

It is obtainable in 10ce. rubber-stopper-

I

I

ed vials,. each containing the equivalent of 0.7 grams of
I
I

the Bolid mat$rial.
I

In the average case of granulocyto-

penia with a .hite count between 1000 and 2000 per c.mm.,
0.7 grEtm i B given intramuscularly two, or preferrably,
!

three times a day until the white count ha.s definitely
I

!

i

risen 'and 'yourflg neutrophilE! have appeared.

This cha.nge

!

"~

usually

occur~

on or about the fif'th

d~ay

oI~

trea. tment.
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0.7 grems is then given daily until the white count has
been normel for severel days.
sick, and

e~pecially

In cases which are extremely

in those in which the total white

count is below 1000, 40 cc. should b e given dAily until
the white count has definitely risen and young neutropal1s
ere present.
ously.

Fifty cc. may be given even more advantage-

The drug may also be administered intravenously,

well diluted in saline, by the continuous drip method,
the speed of injection being such that no untoward readtion occurs.

Usually 50 to 100 drops may be given per

minute when 20 cc. ere diluted in 100 cc. of normal saline
solution.

The drug should be continued in larger doses

until the white count has definitely risen and in somewha~

shaller amounts until it has been normal for several

days •. If there has been no response in ten days, most
authors consider further therapy useless.
Fitz-Hugh and associates (46) report a reaction of
81arming character but do not sta.te 'Nhether· the drug wa.s
given intramuscularly or intravenously.

They also say

that one of their patients reacted violently with fever
up to 104 degrees with e8ch intramuscular dose bvt tolerated the same doee intravenously without reactidn.

In

some, there is a transient sense of discomfort at the
site of injection.

In others there may be precordial

distress, dyspnea and nausea.

Very rarely are the symptoms
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alarming.

If however they are sufficiently severe

syrr:ptoms to upset, the patient, Jackson and Parker (71)
suggest that smeller doses of the drug be given at more

.

frequent intervals until the required amount is given
daily_
be

They also point out that the drug should never

giv~n

to an anaphylaotic individual nor to one with

severe cardla.c damage.
Doan (80) pOints out that the first sign of a favora.ble reaction to pentnucleotide is evidenced by the a.ppearance of myelocytes in the blood stream.

These cells

may reach twenty per cent of the total white cells.

This

change, he says, usually occurs about the fourth day following treatment and corresponds in some measure to the
reticulocytic rise in pernicious anemia.

Shortly there-

after the temperature fells, the total white count rises,
and more mature neutrophils tpke the pla,oe of the immature cells.
Pentnucleotlde has been used successfully by many
and at present is the treatment advocated by "!lost guthors.
(102), (103), (104)', (105), (106), (107), (109), (93.).'
GENER.A.L CARE.

It stands to reason that intelligent

bedside ce.re, careful nursing, adequate nourishment, and
fluids are all a necessary and o'rvious parts of the treet ...
ment.

The patient· must be protected in so far as possible,

from infection.

But attempts to sterilize the ulcerated
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lesions is detrimental.
and throat

~ith

Frequent washings of the mouth

soothing solutions may allay pain and

make the patient mCJre cOf[;fortable.
It had been suggested by some (Yi'"alker (97), Beck
(1), Roberts and Kracke (lOg), thet Burgical intervention is contra-indic8ted.

Lintz"

Thompson, Jackson and

Parker (71), however, do not agree with this.

They 8.d-

vise eny immediate surgery as would be done in a patient
wi th

B.

normal blood count.

CONCLUSION

An

8tt~mpt

has been made in this paper to review

the literature on granulocytopenia and compile this information in more or less of a textbook fashion.

A

re-

view of the physiology of granulopoesis and pathological
conditions occurring in granulocytopenia was given in
order to gain a more ac·curete understanding of possible
etiological fectors and the validity of each treatment
presented.
From this study, the following facts seem to be of
primary importance:

Whether granulocytopenia is to be

regarded as a disease entity or a syndrome, cannot as
yet be dogmatically steted, but it is probable that such
a disease entity does exist.

The etiology of the dis-

ease is as yet uncertain, however those particuls_r drugs
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containing the benzamine nucleus undoubtedly-do have
much to do with the development of certain cases.
I

p~lthological

The

changes in the bone merrow consists ofa

maturation arrest at the stem cell stage.

Effective

specific treatment is as yet largely limited to the
use of nuclleotides.

The more favorable mortality in

the past yew years has more or les8 pa.ralleled the more
rapid diagnosis

~f

·the disease and the introduction of

the use of nucleotldes in the treatment.

Until' the

nature, etiology and pathology of granulocytosis is unequIvocally placed upon a sound basis, the diagnosis,
treatment and prognosis of the condition will remain
little changed.
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